Disc Medicine Expands Scientific Advisory Board with Leading Experts in Hepcidin Biology

CAMBRIDGE, Mass., Oct. 13, 2020 /PRNewswire/ — Disc Medicine, a company dedicated to the discovery and development of novel therapeutic candidates for serious and debilitating hematologic diseases, today announced the appointment of Tomas Ganz, MD, PhD and Elizabeta Nemeth, PhD to its scientific advisory board, adding valuable expertise in hepcidin biology.

“We are thrilled to welcome  Dr. Ganz and Dr. Nemeth to our Scientific Advisory Board, particularly at such an exciting time in a field that they helped pioneer,” said John Quisel, JD, PhD, Chief Executive Officer at Disc Medicine. “Together they were instrumental in characterizing the fundamental role of hepcidin in iron homeostasis, and I’m delighted to be working with them as we advance our hepcidin-targeted programs into the clinic.”

Dr. Ganz is a Distinguished Professor of Medicine and Pathology at the David Geffen School of Medicine at UCLA, where he studies the role

Read More

How Genexa Is Leading The Clean Medicine Revolution And Getting Us To ‘Ditch The Dirty’

As a parent, I’m always thinking of my six year old son and how to keep him healthy and safe. I was surprised to hear of the idea of ‘clean medicine’ – and learn more about how common medications oftentimes contain ingredients which could be harmful.

Genexa is a ‘clean medicine’ company that is on a mission to get us to ‘Ditch the Dirty’. I caught up with co-founders David Johnson and Max Spielberg to find out more.

Afdhel Aziz: Max, David, welcome. Please tell us how the two of you came to start Genexa?

David Johnson: I grew up in a “nuts and seeds” type of household. My parents, both chiropractors, were particularly cognizant of everything health related. They always tried to choose natural and organic foods.  In having my own kids now, I want to raise them similarly, using the cleanest ingredients

Read More

Trump hails his COVID ‘cure’ as leading medical journal calls him ‘dangerously incompetent’ on pandemic

President Trump continued to hail an experimental monoclonal antibody treatment as a “cure” for COVID-19, telling conservative radio host Rush Limbaugh in a Friday interview that it sped his recovery from the disease and was “better than a vaccine.”

“I was not in great shape, but we have a medicine that healed me, that fixed me,” Trump said of the antibody “cocktail” manufactured by Regeneron Pharmaceuticals. “It’s a great medicine. I recovered immediately.”

Since being released on Monday from Walter Reed National Military Medical Center, where he was treated for three days after being admitted with a high fever, chills and breathing problems, Trump has often pointed to the antibody therapy he undertook at the hospital as a “cure” for COVID-19. There is no known cure for the disease caused by exposure to the coronavirus, and the FDA has not, so far, approved the drug’s use for treating COVID-19.

Just

Read More

Royal Caribbean sued over baby’s illness leading to amputations

CLOSE

Cruise Lines International Association, which represents 95% of the cruise industry, introduced mandatory requirements to be able to set sail again.

USA TODAY

When Aimee and Luke Moon boarded Royal Caribbean’s Symphony of the Seas in February with their 9-month-old, Phoebe, for her first vacation, they couldn’t have imagined the fate that awaited them: a near-death experience and triple amputation for their daughter.

“It was just like a nightmare, you just think it’s not real,” Luke Moon told USA TODAY. “Because nothing was wrong the day before.”

A sick infant daughter later found to have meningococcal meningitis. Five futile infirmary visits. Sixteen hours of agonizing worry. The Moons’ harrowing ordeal shortly after boarding a cruise ship has changed their lives forever and sparked a lawsuit.

“Our thoughts are with the family during this challenging time,” Jonathon Fishman, spokesperson for Royal Caribbean, told USA TODAY. “We do not comment on

Read More